Axogen Inc. (AXGN) Insider Trading

Last 12 months

Insiders sold $19.3M and bought nothing on the open market.

36% of the selling was scheduled in advance under 10b5-1 plans. Chief Executive Officer Michael D Dale sold $1.92M on Dec 9, 2025, 41% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2023.

Net open-market

−$19.3M

0 buys · 27 sales

Under a 10b5-1 plan

36%

of the value sold

Insiders who bought / sold

0 / 12

executives and directors

Last open-market buy

Sep 2023

Sep 6, 2023

Get an email when AXGN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 2	Joseph A. Tyndall Director	Sold10b5-1 plan	3,500	$49.70	$174k	25%	Form 4
Aug 11	Amy McBride Wendell Director	Sold10b5-1 plan	13,353	$48.42	$647k	11%	Form 4
Aug 10	Marc A Began EVP & General Counsel	Sold10b5-1 plan	67,500	$47.35	$3.2M	57%	Form 4
Aug 7	Kathy Johnson Weiler Director	Sold10b5-1 plan	14,150	$45.30	$641k	100%	Form 4
May 8	Amy McBride Wendell Director	SoldNo plan	1,647	$42.60	$70k	1.7%	Form 4
May 7	John Johnson Director	SoldNo plan	11,050	$43.26	$478k	100%	Form 4
May 7	Kathy Johnson Weiler Director	SoldNo plan	16,344	$44.09	$721k	100%	Form 4
May 7	Jens Kemp Chief Marketing Officer	SoldNo plan	4,000	$43.44	$174k	5.2%	Form 4
May 7	Lindsey Marie Hartley CFO	SoldNo plan 2 parts	1,051	$43.67 average	$46k	1.6%	Form 4
May 7	Doris Quackenbush Sales VP	SoldNo plan	3,878	$43.51	$169k	4.0%	Form 4
Mar 16	Erick Wayne Devinney Chief Innovation Officer	SoldNo plan	5,221	$32.84	$171k	1.9%	Form 4
Dec 16, 2025	Amy McBride Wendell Director	SoldNo plan 3 parts	43,684	$29.31 average	$1.28M	32%	Form 4
Dec 16, 2025	Kathy Johnson Weiler Director	SoldNo plan 3 parts	46,653	$29.55 average	$1.38M	100%	Form 4
Dec 15, 2025	Lindsey Marie Hartley CFO	SoldNo plan	14,812	$29.86	$442k	32%	Form 4
Dec 11, 2025	Marc A Began EVP & General Counsel	SoldNo plan	13,222	$30.00	$397k	42%	Form 4
Dec 10, 2025	Michael D Dale Chief Executive Officer	SoldNo plan	25,000	$30.00	$750k	28%	Form 4
Dec 8, 2025 – Dec 9, 2025	John Johnson Director	SoldNo plan 4 parts	45,379	$30.64 average	$1.39M	100%	Form 4
Dec 9, 2025	Michael D Dale Chief Executive Officer	SoldNo plan	61,463	$31.21	$1.92M	41%	Form 4
Dec 9, 2025	Joseph A. Tyndall Director	SoldNo plan 2 parts	25,108	$30.98 average	$778k	100%	Form 4
Dec 9, 2025	Erick Wayne Devinney Chief Innovation Officer	SoldNo plan	19,517	$31.21	$609k	7.5%	Form 4
Dec 9, 2025	Jens Kemp Chief Marketing Officer	SoldNo plan	8,156	$31.21	$255k	15%	Form 4
Dec 9, 2025	Marc A Began EVP & General Counsel	SoldNo plan	9,278	$31.21	$290k	23%	Form 4
Dec 9, 2025	Paul Thomas Director	SoldNo plan	21,399	$29.61	$634k	61%	Form 4
Dec 8, 2025	Lindsey Marie Hartley CFO	SoldNo plan 2 parts	14,387	$31.56 average	$454k	31%	Form 4
Nov 10, 2025 – Nov 11, 2025	William P. Mr. Burke Director	Sold10b5-1 plan 2 parts	22,818	$24.01 average	$548k	100%	Form 4
Nov 5, 2025 – Nov 6, 2025	William P. Mr. Burke Director	Sold10b5-1 plan 2 parts	16,778	$24.04 average	$403k	99%	Form 4
Oct 29, 2025 – Oct 30, 2025	William P. Mr. Burke Director	Sold10b5-1 plan 3 parts	58,483	$21.32 average	$1.25M	100%	Form 4
Oct 22, 2025	William P. Mr. Burke Director	Sold10b5-1 plan	1,457	$18.02	$26k	94%	Form 4
Oct 6, 2025	William P. Mr. Burke Director	Sold10b5-1 plan	736	$18.00	$13k	32%	Form 4
Oct 2, 2025 – Oct 3, 2025	William P. Mr. Burke Director	Sold10b5-1 plan 4 parts	32,191	$18.15 average	$584k	76%	Form 4
Sep 16, 2025	Erick Wayne Devinney Chief Innovation Officer	SoldNo plan	1,137	$16.29	$19k	0.5%	Form 4
Jun 10, 2025	Joseph A. Tyndall Director	SoldNo plan	26,931	$10.72	$289k	100%	Form 4
Jun 9, 2025	Kathy Johnson Weiler Director	SoldNo plan	4,073	$10.61	$43k	38%	Form 4
Jun 9, 2025	Alan M Levine Director	SoldNo plan	4,073	$10.61	$43k	10.0%	Form 4
Jun 9, 2025	Amy McBride Wendell Director	SoldNo plan	4,073	$10.61	$43k	4.2%	Form 4
Jun 9, 2025	William P. Mr. Burke Director	SoldNo plan	4,073	$10.61	$43k	14%	Form 4
Jun 9, 2025	Guido J Neels Director	SoldNo plan	4,073	$10.61	$43k	4.5%	Form 4
Jun 9, 2025	John Johnson Director	SoldNo plan	4,073	$10.61	$43k	14%	Form 4
May 22, 2025	Joseph A. Tyndall Director	SoldNo plan 2 parts	20,062	$11.20 average	$225k	57%	Form 4
May 19, 2025	Joseph A. Tyndall Director	SoldNo plan	2,525	$11.63	$29k	10%	Form 4

Sep 210b5-1 plan
Joseph A. Tyndall
Director · sold 3,500 at $49.70
$174k
25% of stake
Aug 1110b5-1 plan
Amy McBride Wendell
Director · sold 13,353 at $48.42
$647k
11% of stake
Aug 1010b5-1 plan
Marc A Began
EVP & General Counsel · sold 67,500 at $47.35
$3.2M
57% of stake
Aug 710b5-1 plan
Kathy Johnson Weiler
Director · sold 14,150 at $45.30
$641k
100% of stake
May 8No plan
Amy McBride Wendell
Director · sold 1,647 at $42.60
$70k
1.7% of stake
May 7No plan
John Johnson
Director · sold 11,050 at $43.26
$478k
100% of stake
May 7No plan
Kathy Johnson Weiler
Director · sold 16,344 at $44.09
$721k
100% of stake
May 7No plan
Jens Kemp
Chief Marketing Officer · sold 4,000 at $43.44
$174k
5.2% of stake
May 7No plan
Lindsey Marie Hartley
CFO · sold 1,051 at avg $43.67
$46k
1.6% of stake
May 7No plan
Doris Quackenbush
Sales VP · sold 3,878 at $43.51
$169k
4.0% of stake
Mar 16No plan
Erick Wayne Devinney
Chief Innovation Officer · sold 5,221 at $32.84
$171k
1.9% of stake
Dec 16, 2025No plan
Amy McBride Wendell
Director · sold 43,684 at avg $29.31
$1.28M
32% of stake
Dec 16, 2025No plan
Kathy Johnson Weiler
Director · sold 46,653 at avg $29.55
$1.38M
100% of stake
Dec 15, 2025No plan
Lindsey Marie Hartley
CFO · sold 14,812 at $29.86
$442k
32% of stake
Dec 11, 2025No plan
Marc A Began
EVP & General Counsel · sold 13,222 at $30.00
$397k
42% of stake
Dec 10, 2025No plan
Michael D Dale
Chief Executive Officer · sold 25,000 at $30.00
$750k
28% of stake
Dec 8, 2025 – Dec 9, 2025No plan
John Johnson
Director · sold 45,379 at avg $30.64
$1.39M
100% of stake
Dec 9, 2025No plan
Michael D Dale
Chief Executive Officer · sold 61,463 at $31.21
$1.92M
41% of stake
Dec 9, 2025No plan
Joseph A. Tyndall
Director · sold 25,108 at avg $30.98
$778k
100% of stake
Dec 9, 2025No plan
Erick Wayne Devinney
Chief Innovation Officer · sold 19,517 at $31.21
$609k
7.5% of stake
Dec 9, 2025No plan
Jens Kemp
Chief Marketing Officer · sold 8,156 at $31.21
$255k
15% of stake
Dec 9, 2025No plan
Marc A Began
EVP & General Counsel · sold 9,278 at $31.21
$290k
23% of stake
Dec 9, 2025No plan
Paul Thomas
Director · sold 21,399 at $29.61
$634k
61% of stake
Dec 8, 2025No plan
Lindsey Marie Hartley
CFO · sold 14,387 at avg $31.56
$454k
31% of stake
Nov 10, 2025 – Nov 11, 202510b5-1 plan
William P. Mr. Burke
Director · sold 22,818 at avg $24.01
$548k
100% of stake
Nov 5, 2025 – Nov 6, 202510b5-1 plan
William P. Mr. Burke
Director · sold 16,778 at avg $24.04
$403k
99% of stake
Oct 29, 2025 – Oct 30, 202510b5-1 plan
William P. Mr. Burke
Director · sold 58,483 at avg $21.32
$1.25M
100% of stake
Oct 22, 202510b5-1 plan
William P. Mr. Burke
Director · sold 1,457 at $18.02
$26k
94% of stake
Oct 6, 202510b5-1 plan
William P. Mr. Burke
Director · sold 736 at $18.00
$13k
32% of stake
Oct 2, 2025 – Oct 3, 202510b5-1 plan
William P. Mr. Burke
Director · sold 32,191 at avg $18.15
$584k
76% of stake
Sep 16, 2025No plan
Erick Wayne Devinney
Chief Innovation Officer · sold 1,137 at $16.29
$19k
0.5% of stake
Jun 10, 2025No plan
Joseph A. Tyndall
Director · sold 26,931 at $10.72
$289k
100% of stake
Jun 9, 2025No plan
Kathy Johnson Weiler
Director · sold 4,073 at $10.61
$43k
38% of stake
Jun 9, 2025No plan
Alan M Levine
Director · sold 4,073 at $10.61
$43k
10.0% of stake
Jun 9, 2025No plan
Amy McBride Wendell
Director · sold 4,073 at $10.61
$43k
4.2% of stake
Jun 9, 2025No plan
William P. Mr. Burke
Director · sold 4,073 at $10.61
$43k
14% of stake
Jun 9, 2025No plan
Guido J Neels
Director · sold 4,073 at $10.61
$43k
4.5% of stake
Jun 9, 2025No plan
John Johnson
Director · sold 4,073 at $10.61
$43k
14% of stake
May 22, 2025No plan
Joseph A. Tyndall
Director · sold 20,062 at avg $11.20
$225k
57% of stake
May 19, 2025No plan
Joseph A. Tyndall
Director · sold 2,525 at $11.63
$29k
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AXGN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Electromedical & Electrotherapeutic Apparatus

INMDInMode Ltd.

OMOutset Medical Inc.

ZYXIQZynex Inc

FONRFonar Corp

BLFSBiolife Solutions Inc.

CBLLCeribell, Inc.

VASOVaso Corporation

ELMDElectromed Inc.

Spot a number that looks wrong? Check it in AXGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AXGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.